Picture of Athenex logo

ATNXQ — Athenex News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Athenex Voluntarily Files Chapter 11 Proceedings

May 14 (Reuters) - Athenex Inc  ATNX.O :
    * COMPANY HAS SUFFICIENT RESOURCES TO SUPPORT ATHENEX PHARMA
SOLUTIONS OPERATIONS AND FULFILL APD CUSTOMER ORDERS DURING
PROCESS
    * COMPANY VOLUNTARILY FILES CHAPTER 11 PROCEEDINGS
    * HAS REACHED AGREEMENT WITH LENDERS FOR SALE OF CO'S ASSETS
ACROSS ATHENEX PHARMACEUTICAL DIVISION, ORASCOVERY, CELL THERAPY
    * COMPANY ANTICIPATES CONCLUDING EXPEDITED SALES PROCESS BY
JULY
1, 2023
    * ATHENEX PHARMA SOLUTIONS IS EXPECTED TO CONTINUE ITS
OPERATIONS
FOR AT LEAST NEXT 90 DAYS

Source text for Eikon:  urn:newsml:reuters.com:*:nGNX1QDj4b
Further company coverage:  ATNX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Athenex

See all news